The hormone benefits will motivate you to continue. Just do the work to keep bringing it up, and pay attention to symptoms. You can have a bad day with testosterone, based on sleep, and a host of other factors like stress. That's why symptoms are so important, and getting multiple tests over a longer period. But know that having an abnormal testosterone result doesn’t necessarily mean you have a serious medical condition. Not everyone with low testosterone has symptoms (like low sex drive, fertility problems or erectile dysfunction). The only way to know your testosterone level is with a blood test. An abnormal testosterone test result doesn’t guarantee that you have a medical condition. "Normal" ranges for testosterone also vary significantly based on your age and sex. Testosterone therapy can be considered in those men who have undergone radical prostatectomy (RP) with favorable pathology (e.g., negative margins, negative seminal vesicles, negative lymph nodes), and who have undetectable PSA postoperatively. From a clinical standpoint, it dictates that there is a testosterone threshold beyond which prostate cells (benign or malignant) cease responding. The other men in the study already had metastatic disease at the time of testosterone initiation. Increasing patient age and increasing duration of prior exogenous testosterone use both significantly reduced the likelihood of reaching the 5 million TMSC benchmark. In this population, exogenous testosterone was stopped and combination high-dose hCG and SERM therapy was initiated. Using stricter criteria for inclusion (only RCTs), Cai et al.324 demonstrated minor improvements in triglycerides (-13.5 mg/dL) among testosterone treated men in 4 RCTs of men with testosterone deficiency. A similar meta-analysis of only RCTs demonstrated no changes in total cholesterol or triglycerides in men who were on testosterone as compared to those on placebo. Millions of American men use a prescription testosterone injection or gel as forms of testosterone replacement therapy (often referred to as TRT therapy) to restore normal levels of the manly hormone. Since the FDA warning in 2015, other studies have failed to demonstrate a risk of cardiovascular events in patients on testosterone therapy. Although the committee reviewing the evidence concluded that there was not enough data to definitively state that testosterone therapy posed a significant cardiovascular risk, the FDA nonetheless required testosterone product manufacturers to add information to the labeling about a possible increased risk of myocardial infarction and cerebrovascular accidents in patients using testosterone therapy. Mean peak total testosterone levels are dose-dependent, with a mean of 746, 866, and 913 ng/dL noted with 8, 10, and 12 pellets administered (not BMI adjusted).446 The duration of effect is similar, however, and is relatively independent of dosing. Men with total testosterone level 315 ng/dL declined from 100% at 4 weeks to 86%, 75%, and 14% by 12, 20, and 24 weeks, respectively.Mean peak total testosterone levels are dose-dependent, with a mean of 746, 866, and 913 ng/dL noted with 8, 10, and 12 pellets administered (not BMI adjusted).446 The duration of effect is similar, however, and is relatively independent of dosing. Administration of 750 mg of IM testosterone undecanoate at weeks 0, 4, and every 10 weeks thereafter maintained total testosterone levels between 300-1,000 ng/dL for 94% of men.438 No men experienced maximal values Adverse Effects. Early morning samples from each subject's most recent and previous 3 visits as well as those from 10, 15, 20, 25, and 30 years prior were analyzed (3,565 samples total with a mean of 4 samples per patient). Given these inconsistences, prevalence of low testosterone has varied dramatically among studies, with statistics reporting %.5-8 A summary of findings from four large-scale contemporary prevalence studies can be found in Table 3 (See button below). Across the prevalence literature, the cut-off values used to define low testosterone vary widely, heterogeneity exists in the populations studied, the forms of testosterone used to measure testosterone (total and/or free) are not consistent, and the assays utilized to measure testosterone differ. A review by Millar et al.4 searched MEDLINE and Embase databases from January 1966 to July 2014 for studies that compared clinical indication of low testosterone along with a measurement of serum testosterone in men. The prevalence of testosterone deficiency in the American male population is difficult to quantify. Finally, testosterone pellets are also available in branded form, with no generic agents currently available. Seven to nine hours of consistent sleep can increase testosterone and improve GH/IGF‑1 signaling. Blood pressure, lipids, sleep apnea, hematocrit, and smoking status deserve attention before and during therapy. If hematocrit climbs, your clinician may lower the dose, split injections, switch formulations, or pause therapy. Testosterone therapy suppresses sperm production, sometimes to zero, within months. Expect sexual benefits within weeks, energy and mood within 1–2 months, and body composition changes over 3–6 months alongside resistance training and protein intake. These aren’t always permanent exclusions, but they require careful specialist management. Females typically have much lower testosterone levels than males. Low testosterone levels for adult premenopausal females are 10 to 55 ng/dL, and for postmenopausal females, 7 to 40 ng/dL. Some research also suggests that high levels of prenatal testosterone levels may be linked to autism in children. However, there’s no official consensus on healthy testosterone levels.
